Oncology Institute, Inc.
DFPH$434M
Small CapNASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
DFPH News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Nab paclitaxel | Phase 2 | Pancreatic Cancer | - | - |
Oral Tablet: Cabozantinib | Phase 2 | Colorectal Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply